In the Original Investigation titled “Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Final Results of a Phase 2 Study,”¹ published online July 20, 2017, there were errors in Figure 2a in the numbers at risk at 24, 48, 72, and 96 months. The correct numbers at risk are as follows: for overall survival, 36, 17, 11, and 2, and for progression-free survival, 21, 13, 8, and 1, respectively. This article was corrected online.

中文翻译：

---

图错误

在2017年7月20日在线发表的标题为“不可切除的III期非小细胞肺癌的质子束放射疗法和同步化学疗法：2期研究的最终结果”的原始研究中，^1的图2a中的数字有误在24、48、72和96个月时有风险。正确的风险数字如下：总体生存期分别为36、17、11和2，无进展生存期分别为21、13、8和1。本文已在线更正。